1 / 63

Leicester Warwick Medical School

Leicester Warwick Medical School. Cellular Adaptations Dr Gerald Saldanha Department of Pathology Email: gss4@le.ac.uk. Introduction. This presentation will …. Focus on adaptive responses in cell growth & differentiation Describe cell signalling pathways Introduce the cell cycle.

willman
Download Presentation

Leicester Warwick Medical School

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Leicester Warwick Medical School Cellular Adaptations Dr Gerald Saldanha Department of Pathology Email: gss4@le.ac.uk

  2. Introduction • This presentation will …. • Focus on adaptive responses in cell growth & differentiation • Describe cell signalling pathways • Introduce the cell cycle

  3. Control of cell growth • Cells in a multicellular organism communicate through chemical signals • Hormones act over a long range • Local mediators are secreted into the local environment • Some cells communicate through direct cell-cell contact

  4. Control of cell growth • Cells are stimulated when extra cellular signalling molecules bind to a receptor • Each receptor recognises a specific protein (ligand) • Receptors act as transducers that convert the signal from one physical form to another.

  5. Signalling molecules • Most signalling molecules cannot pass through the cell membrane • Their receptors are in the cell membrane • Small hydrophobic signal molecules can diffuse directly into the cell cytoplasm • Their receptors are cytoplasmic or nuclear

  6. Signalling molecules • Hormones • Insulin, • Cortisol • etc • Local mediators • Epidermal Growth Factor (EGF), • Platelet Derived Growth Factor (PDGF) • Fibroblast Growth Factor (FGF) • TGF • Cytokines, e.g. Interferons, Tumour necrosis factor (TNF)

  7. Receptors • There are three main classes of receptors…. • Ion-channel-linked receptors • G-protein-linked receptors • Enzyme-linked receptors

  8. Receptors • Ion channel-linked receptors are important in neural signalling • G-protein and enzyme linked receptors respond by activating cascades of intracellular signals • These signals alter the behaviour of the cell

  9. G-protein-linked receptors • G-protein-linked receptors activate a class of GTP-binding proteins (G-proteins) • G proteins are molecular switches • They are turned on for brief periods while bound to GTP • They switch themselves off by hydrolysing GTP to GDP

  10. G proteins • Some G proteins directly regulate ion channels • Others activate adenylate cyclase, thus increasing intracellular cyclic AMP • Some activate the enzyme Phospholipase C, thus increasing intracellular inositol triphosphate (IP3) and Diacylglycerol (DAG)

  11. Enzyme-linked receptors • Many receptors have intracellular domains with enzyme function • Most are receptor tyrosine-kinases • They phosphorylate tyrosine residues in selected intracellular proteins • These receptors are activated by growth factors, thus being important in cell proliferation

  12. Receptor tyrosine kinases • Receptor tyrosine kinase activation results in assembly of an intracellular signalling complex • This complex activates a small GTP-binding protein, Ras • Ras activates a cascade of protein kinases that relay the signal to the nucleus • Mutations that make Ras hyperactive are a common way of inducing increased proliferation in cancer

  13. Signalling: cytoplasm to nucleus • Many signalling cascades culminate in activation of nuclear transcription factors • Transcription factors alter gene expression • C-jun and c-fos ( that form an AP1 complex) and c-myc are three important transcription factors

  14. Signalling pathway interactions • There are many signalling molecules and receptors • A given cell expresses only a subset of receptors • Different intracellular signalling pathways interact • This enables cells to respond appropriately to complex combinations of signals

  15. Cell signalling and proliferation • Animal cells proliferate when stimulated by growth factors • These bind mainly to receptor tyrosine kinases • These signalling pathways override the normal brakes on proliferation • These brakes are part of the cell cycle control system • This ensures that cells divide only under appropriate circumstances

  16. The cell cycle • The eukaryotic cell cycle consists of distinct phases • The most dramatic events are nuclear division (mitosis) and cytoplasmic division (cytokinesis) • This is the M phase • The rest of the cell cycle is called interphase which is, deceptively, uneventful • During interphase the cell replicates its DNA, transcribes genes, synthesises proteins and grows in mass

  17. Phases of the cell cycle • S phase – DNA replicates • M phase – nucleus divides (mitosis) and cytoplasm divides (cytokinesis) • G1 phase – gap between M and S phase • G2 phase – between S and M phase

  18. Cell cycle control • Cell cycle machinery is subordinate to a cell cycle control system • The control system consists mainly of protein complexes • These complexes consist of a cyclin subunit and a Cdk subunit • The cyclin has regulatory function, the Cdk catalytic function

  19. Cell cycle control • Cdk expression is constant, but cyclin concentrations rise and fall at specific times in the cell cycle • The Cdks are cyclically activated by cyclin binding and by phosphorylation status • Once activated, Cdks phosphorylate key proteins in the cell

  20. Cell cycle control • Different cyclin-Cdk complexes trigger different cell cycle steps • Some drive the cell into M phase, others into S phase • The cell cycle control system has in-built molecular breaks (checkpoints) • The checkpoints ensure that the next step does not begin until the previous one is complete

  21. The G1 checkpoint • The G1 checkpoint has been widely studied • The retinoblastoma (Rb) protein plays a key role at this checkpoint • The Rb protein function is determined by its phosphorylation status • S phase cyclin-Cdk complexes phosphorylate Rb

  22. The G1 checkpoint • This checkpoint is influenced by the action of cyclin-dependant kinase inhibitors (CKIs, e.g. p21, p16) • E.g. p53 senses DNA damage and induces p21 expression • CKIs inactivate cyclin-Cdk complexes

  23. Cellular adaptations of growth and differentiation • Cells must respond to a variety of stimuli that may be hormonal, paracrine or through direct cell contact • These stimuli may arise under physiological or pathological conditions • The way that cells adapt in terms of growth and differentiation depends in part on their ability to divide

  24. Cellular proliferative capacity • Tissues can be classified according to the ability of their cells to divide • Some tissues contain a pool of cells that move rapidly from one cell cycle to the next. These are labile cells

  25. Cellular proliferative capacity • Some cells dismantle their cell cycle control machinery and exit the cell cycle • These cells are said to be in G0. • Some of these cellscan re-enter the cell cycle when stimulated, e.g. by growth factors. These are stable cells • Others are unable to re-enter the cell cycle. These are permanent cells

  26. Growth and differentiation responses • Hyperplasia • Hypertrophy • Atrophy • Metaplasia

  27. Hyperplasia • Increase in the number of cells in an organ or tissue, which may then have an increased size

  28. Hyperplasia: causes • Hyperplasia can only occur in tissues containing labile or stable cells • Hyperplasia may occur under pathological or physiological conditions

  29. Physiological Hyperplasia • Hormonal e.g. endometrium • Compensatory, e.g. partial hepatectomy • TGF alpha, HGF • TGF beta

  30. Pathological hyperplasia • Excessive hormone/growth factor stimulation • Often occurs alongside hypertrophy • Associated with increased risk for cancer • E.g. Prostate, endometrium

  31. Hypertrophy • An increase in cell size, and resultant increase in organ size

  32. Hypertrophy: causes • Occurs in permanent cells • Due to synthesis of more cellular structural components • Physiological or pathological causes

  33. Physiological hypertrophy • Increased functional demand, e.g. skeletal muscle • Mechanical • Hormonal, e.g. Uterus in pregnancy • Usually a combination of hypertrophy and hyperplasia

  34. Pathological hypertrophy • Increased functional demand e.g. cardiac muscle • Hypertension • valvular heart disease

More Related